Save the date: Premium subscriber-exclusive Post-Hoc Live

Q1 earnings recap with Endpoints News After a deal-heavy first quarter, earnings season is in full swing. We're breaking down the news and trends from Big Pharma's first-quarter calls on a special premium subscriber-exclusive episode ...